Table 6.
JI predicted drug-disease associations (top 10 in ranking list), and the corresponding evidence
| Drug | Disease | Evidence (PMID) | Rank |
|---|---|---|---|
| Alprostadil | Tetralogy of Fallot | 3543871 | 1 |
| Alprostadil | Tricuspid Atresia | without evidence | 2 |
| Alprostadil | Hypoplastic Left Heart Syndrome | without evidence | 3 |
| Cefepime | Escherichia coli Infections | 26815433 | 4 |
| Cefepime | Urinary Tract Infections | 26243291;1804010 | 5 |
| Atorvastatin | Hypercholesterolemia | 24593216;20946910;20135644 | 6 |
| Cefotaxime | Escherichia coli Infections | without evidence | 7 |
| Clofibrate | Hypercholesterolemi | 1175893;7080553;7157849 | 8 |
| Fenofibrate | Hypercholesterolemi | 2492189;24593216;2045526 | 9 |
| Levofloxacin | Escherichia coli Infections | without evidence | 10 |
The entries in boldface represent the drug-disease associations supported by recent papers in PubMed but not included in CTD